Alimera Sciences, Inc. (ALIM) Social Stream



Alimera Sciences, Inc. (ALIM): $6.73

-0.04 (-0.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Alimera Sciences Inc (ALIM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALIM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-29 1 $12 $12 $12 $5.65 112.39%
2022-02-25 1 $10 $10 $10 $5.65 76.99%

Price Target Last Issued February 25, 2022

The Trend in the Analyst Price Target


ALIM's average price target has moved down $3.5 over the prior 14 months.

Over the past 46 weeks, ALIM's average upside potential has been 109.28%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 0 18 10 14.25 9.56 49.06%
2021-07-24 0 18 15 16.38 8.91 83.84%
2021-08-01 0 18 15 16.38 8.83 85.5%
2021-08-14 0 18 15 16.38 7.31 124.08%
2021-09-04 0 18 12 14.88 6.02 147.18%

ALIM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


ALIM's average broker recommendation rating improved by 1 over the prior 123 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Alimera Sciences Inc's number of analysts covering the stock is greater than just about none of of them.
  • ALIM has a lower variance in analysts' estimates than just about 100% of all US stocks.
  • Alimera Sciences Inc's average analyst price target is greater than 35.18% of Healthcare stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Alimera Sciences Inc's upside potential (average analyst target price relative to current price) is greater than 70.22% of them.

In the Pharmaceutical Products industry, ALDX, ALBO, and AKUS are the three stocks most similar to Alimera Sciences Inc regarding the price target and analyst recommendation information presented here.

Is ALIM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5676 seconds.